CSPC Pharmaceutical (1093 HK) – mRNA platform verified with product approval
CSPC reported FY22 revenue of RMB30.94bn (+11.0% YoY) and attributable net profit of RMB6.09bn (+8.7% YoY), in line with our estimates of...
427 Views
China Clears First Homegrown MRNA Covid Vaccine
China approved its first homegrown Covid-19 vaccine using the advanced mRNA technology, months after the country pivoted from its “zero-Covid”...
407 Views
CSPC Pharmaceutical (1093 HK) – Promising clinical progress of mRNA COVID-19 vaccine candidate
CSPC reported 9M22 revenue of RMB23.5bn, up by 13.8% YoY (+15.6% YoY for 3Q22), and attributable net profit of RMB4.5bn, up by 3.1% YoY
290 Views
CX Daily: China Turns to Credit Easing to Kick-Start Sluggish Economy
In Depth: China turns to credit easing to kick-start sluggish economy. Shanghai reverses Covid separation policy to let families stay with their...
197 Views
Upcoming Quarterly Earnings Releases for Single Stock DLCs
DLCs, which offer flexibility to trade both rising and falling markets, provide long and short 5x leveraged exposure on the daily performance...
113 Views